Genetic predisposition to cancer

Clinical Medicine, Journal of the Royal College of Physicians of London

Volumn 5, Issue 5, 2005, Pages 491-498

  Turnbull, Clare ^a   Hodgson, Shirley ^b  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^b ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

Breast; Cancer; Colorectal; Genes; Genetic; Hereditary; Inherited; Monogenic; Predisposition; Surveillance

Indexed keywords

BRCA1 ASSOCIATED RING DOMAIN PROTEIN 1; BRCA2 PROTEIN;

ADENOMATOUS POLYP; ATAXIA TELANGIECTASIA; BREAST CANCER; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SUSCEPTIBILITY; CHEMOPROPHYLAXIS; COLONOSCOPY; COLORECTAL CANCER; CONFIDENCE INTERVAL; COWDEN SYNDROME; ENVIRONMENTAL FACTOR; FAMILIAL CANCER; FAMILY; FAMILY HISTORY; GENETIC ANALYSIS; GENETIC PREDISPOSITION; HUMAN; INCIDENCE; ONCOGENE; PEUTZ JEGHERS SYNDROME; PREDICTION; RESEARCH; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 27144456829     PISSN: 14702118     EISSN: None     Source Type: Journal    
DOI: 10.7861/clinmedicine.5-5-491     Document Type: Review

References (34)

1. Lovett E. Family studies in cancer of the colon and rectum. Br J Surg 1976;63:13-8.
2. Pharoah PD, Day NE, Duffy S, Easton DF, Ponder BA. Family history and the risk of breast cancer: a systematic review and meta-analysis. Int J Cancer 1997;71:800-9.
3. St John DJ, McDermott FT, Hopper JL, Debney EA et al. Cancer risk in relatives of patients with common colorectal cancer. Ann Intern Med 1993;118:785-90.
4. Kash KM, Ortega-Verdejo K, Dabney MK, Holland JC et al. Psychosocial aspects of cancer genetics: women at high risk for breast and ovarian cancer. Semin Surg Oncol 2000;18:333-8.
5. Jemal A, Tiwari RC, Murray T, Ghafoor A et al. Cancer statistics, 2004. Review. CA Cancer J Clin 2004;54:8-29.
6. Eeles RA, Easton DF, Ponder BA, Eng C (eds). Genetic predisposition to cancer, 2nd edn. London: Arnold, 2004.
7. Claus EB, Risch N, Thompson WD. Genetic analysis of breast cancer in the cancer and steroid hormone study. Am J Hum Genet 1991;48:232-42.
8. Thompson D, Easton DF; Breast Cancer Linkage Consortium. Cancer incidence in BRCA1 mutation carriers. J Natl Cancer Inst 2002;94:1358-65.
9. Cancer risks in BRCA2 mutation carriers. The Breast Cancer Linkage Consortium. J Natl Cancer Inst 1999;91:1310-6.
10. Le Bihan C, Bonaiti-Pellie C. A method for estimating cancer risk in p53 mutation carriers. Cancer Detect Prev 1994;18:171-8.
11. Eng C. Genetics of Cowden syndrome: through the looking glass of oncology. Review. Int J Oncol 1998;12:701-10.
12. Hall JM, Lee MK, Newman B, Morrow JE et al. Linkage of early-onset familial breast cancer to chromosome 17q21. Science 1990;250:1684-9.
13. Wooster R, Neuhausen SL, Mangion J, Quirk Y et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 1994;265:2088-90.
14. Leach MO, Eeles RA, Turnbull LW, Dixon AK et al. The UK national study of magnetic resonance imaging as a method of screening for breast cancer (MARIBS). J Exp Clin Cancer Res 2002;21:107-14.
15. Li FP, Fraumeni JF Jr. Rhabdomyosarcoma in children: epidemiologic study and identification of a familial cancer syndrome. J Natl Cancer Inst 1969;43:1365-73.
16. Lane DP. Cancer. p53, guardian of the genome. Nature 1992;358:15-6.
17. Nichols KE, Malkin D, Garber JE, Fraumeni JF Jr, Li FP. Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers. Cancer Epidemiol Biomarkers Prev 2001;10:83-7.
18. Olsen JH, Hahnemann JM, Borresen-Dale AL, Brondum-Nielsen K et al. Cancer in patients with ataxia-telangiectasia and in their relatives in the nordic countries. J Natl Cancer Inst 2001;93:121-7.
19. Athma P, Rappaport R, Swift M. Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer. Cancer Genet Cytogenet 1996;92:130-4.
20. Meijers-Heijboer H, van den Ouweland A, Klijn J, Wasielewski M et al. Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat Genet 2002;31:55-9.
21. Krontiris TG, Devlin B, Karp DD, Robert NJ, Risch N. An association between the risk of cancer and mutations in the HRAS1 minisatellite locus. N Engl J Med 1993;329:517-23.
22. National Institute for Health and Clinical Excellence. Familial breast cancer. London: NICE, 2005.
23. Potter JD. Nutrition and colorectal cancer. Review. Cancer Causes Control 1996;7:127-46.
24. Boutron MC, Faivre J, Quipourt V, Senesse P, Michiels C. Family history of colorectal tumours and implications for the adenoma-carcinoma sequence: a case control study. Gut 1995;37:830-4.
25. Ponz de Leon M, Sassatelli R, Sacchetti C, Zanghieri G et al. Familial aggregation of tumors in the three-year experience of a population-based colorectal cancer registry. Cancer Res 1989;49:4344-8.
26. Spigelman AD, Murday V, Phillips RK. Cancer and the Peutz-Jeghers syndrome. Gut 1989;30:1588-90.
27. Giardiello FM, Welsh SB, Hamilton SR, Offerhaus GJ et al. Increased risk of cancer in the Peutz-Jeghers syndrome. N Engl J Med 1987;316:1511-4.
28. Knudsen AL, Bisgaard ML, Bulow S. Attenuated familial adenomatous polyposis (AFAP). A review of the literature. Fam Cancer 2003;2:43-55.
29. Kee F, Collins BJ. How prevalent is cancer family syndrome? Gut 1991;32:509-12.
30. Lynch HT, de la Chapelle A. Genetic susceptibility to non-polyposis colorectal cancer. Review. J Med Genet 1999;36:801-18.
31. Sieber OM, Lipton L, Crabtree M, Heinimann K et al. Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. N Engl J Med 2003;348:791-9.
32. Westergaard H. Colorectal cancer: the role of screening and surveillance. Review. J Investig Med 1996;44:216-27.
33. Hodgson SV, Maher ER. A practical guide to human cancer genetics, 2nd edn. Cambridge: Cambridge University Press, 1999.
34. Bradshaw N, Holloway S, Penman I, Dunlop MG, Porteous ME. Colonoscopy surveillance of individuals at risk of familial colorectal cancer. Gut 2003;52:1748-51.